Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LASS6 |
| Upstream (Parents) |
|---|
| (<<) EN1 → LASS6 |
| (<<) FOXC1 → LASS6 |
| (<<) SPDEF → LASS6 |
| (<<) HOXB3 → LASS6 |
| (<<) CREB3L4 → LASS6 |
| (<<) XBP1 → LASS6 |
| (<<) HOXB2 → LASS6 |
| (<<) TFDP1 → LASS6 |
| (<<) NFYA → LASS6 |
| (<<) KDM5A → LASS6 |
| (<<) CSDA → LASS6 |
| (<<) ZFHX4 → LASS6 |
| (<<) ZNF138 → LASS6 |
| (<<) ATF6 → LASS6 |
| (<<) ATF7 → LASS6 |
| (<<) GATAD2B → LASS6 |
| Downstream (Children) |
|---|
| LASS6 → GATA3 (>>) |
| LASS6 → SIX3 (>>) |
| LASS6 → TRIM29 (>>) |
| LASS6 → GATA6 (>>) |
| LASS6 → NFIB (>>) |
| LASS6 → SIX2 (>>) |
| LASS6 → ASCL2 (>>) |
| LASS6 → ZNF238 (>>) |
| LASS6 → KLF4 (>>) |
| LASS6 → SLC30A9 (>>) |
| LASS6 → HES6 (>>) |
| LASS6 → RARA (>>) |
| LASS6 → VDR (>>) |
| LASS6 → HDX (>>) |
| LASS6 → TEAD1 (>>) |
| LASS6 → RERE (>>) |
